Practical guidance on the clinical management of ocular adverse events associated with belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Recommendations from a Japanese expert panel
The recommendations in these practice guidelines build on published clinical trial evidence and the practical experience of the expert panel to help Japanese clinicians make informed treatment decisions in the management of multiple myeloma in the real-world setting.
Authors
- Toshinari Funaki
- Teruhito Takakuwa (ORCID: https://orcid.org/0000-0001-5259-0450)
- Shigeki Ito (ORCID: https://orcid.org/0000-0002-3899-6603)
- Tomoaki Fujisaki
- Michiko Ichii
- Kazuhito Suzuki (ORCID: https://orcid.org/0000-0002-0300-378X)
- Kazutaka Sunami (ORCID: https://orcid.org/0000-0002-8229-7439)
- Koichi Oshima (ORCID: https://orcid.org/0000-0002-0771-3551)
- Morio Matsumoto (ORCID: https://orcid.org/0000-0001-9791-0139)
Institutions
- Jikei University School of Medicine (JP)
- Iwate Medical University (JP)
- Japanese Red Cross Medical Center (JP)
- Saiseikai Wakakusa Hospital (JP)
- Matsuyama Red Cross Hospital (JP)
- Gunma Children's Medical Center (JP)
- Okayama Medical Center (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1093/jjco/hyaf148
- Citations
- 2
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54